Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. Qualifications for this position include a PhD in Computer Science, Artificial Intelligence, Natural Language Processing, Human-Computer Interaction, or a closely related field. Candidates should have demonstrated
-
control programs, research new regulations, and implement approved changes. Manage compliance program for area of responsibility, interpret internal policy and external regulations, and create and/or review
-
requirements and financial covenants. Assist in managing compliance program for area of responsibility, interpret internal policy and external regulations, and create and/or review complex compliance reports
-
candidates. Candidates from groups that are under-represented in their disciplines, including women, ethnic minorities and individuals with disabilities, are encouraged to apply. Complementary programs
-
The goal of the Childhood Research in Obesity Prevention (CROP) program at Stanford University is to advance child health equity. To achieve this goal, the program seeks to translate clinical, community, and
-
a PhD in the field of molecular and cellular cancer biology, relevant publications, curiosity for science and innovative thinking, and high fluency in English. Experience with mammalian cell culture
-
an ACGME-accredited program, and have medical licensure in California by the start date. We are particularly interested in candidates who have strong experience in clinical care and program building
-
for complex functions or programs with significant business, regulatory and/or technical challenges requiring subject matter expertise. May provide development of program or function from initial concept
-
Posted on Thu, 01/30/2025 - 13:06 Important Info Deprecated / Faculty Sponsor (Last, First Name): Smith, Matthew Stanford Departments and Centers: German Studies Postdoc Appointment Term: 2025-26
-
independent program of research focusing on understanding genetic mechanisms and/or translationally applying these findings to developing novel treatments to improve outcomes in pediatric neurogenetic disease